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Abstract
Background: We analyzed HIV testing rates, prevalence of undiagnosed HIV, and predictors of testing in the Kenya AIDS
Indicator Survey (KAIS) 2007.
Methods: KAIS was a nationally representative sero-survey that included demographic and behavioral indicators and testing
for HIV, HSV-2, syphilis, and CD4 cell counts in the population aged 15–64 years. We used gender-specific multivariable
regression models to identify factors independently associated with HIV testing in sexually active persons.
Results: Of 19,840 eligible persons, 80% consented to interviews and blood specimen collection. National HIV prevalence
was 7.1% (95% CI 6.5–7.7). Among ever sexually active persons, 27.4% (95% CI 25.6–29.2) of men and 44.2% (95% CI 42.5–
46.0) of women reported previous HIV testing. Among HIV-infected persons, 83.6% (95% CI 76.2–91.0) were unaware of their
HIV infection. Among sexually active women aged 15–49 years, 48.7% (95% CI 46.8–50.6) had their last HIV test during
antenatal care (ANC). In multivariable analyses, the adjusted odds ratio (AOR) for ever HIV testing in women $35 versus 15–
19 years was 0.2 (95% CI: 0.1–0.3; p,0.0001). Other independent associations with ever HIV testing included urban
residence (AOR 1.6, 95% CI: 1.2–2.0; p=0.0005, women only), highest wealth index versus the four lower quintiles combined
(AOR 1.8, 95% CI: 1.3–2.5; p=0.0006, men only), and an increasing testing trend with higher levels of education. Missed
opportunities for testing were identified during general or pregnancy-specific contacts with health facilities; 89% of adults
said they would participate in home-based HIV testing.
Conclusions: The vast majority of HIV-infected persons in Kenya are unaware of their HIV status, posing a major barrier to
HIV prevention, care and treatment efforts. New approaches to HIV testing provision and education, including home-based
testing, may increase coverage. Targeted interventions should involve sexually active men, sexually active women without
access to ANC, and rural and disadvantaged populations.
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Introduction
HIV testing and counseling (HTC) is the cornerstone of HIV
prevention, care, and treatment. Knowledge of HIV status among
HIV-infected persons is associated with a 60% reduction in
transmission risk behavior [1,2]. HTC is an essential component of
behavioral interventions [3–4] and for targeting specific popula-
tions such as HIV discordant couples [5], children [6] or patients
with sexually transmitted infections (STI) [7]. HTC is a necessary
prerequisite to accessing life-extending care and antiretroviral
treatment for persons with HIV infection. Antiretroviral therapy
for people with HIV has been associated with a 96% reduction in
HIV transmission in discordant couples [8], universal HIV testing
and immediate antiretroviral treatment has been suggested as a
strategy to control generalized HIV epidemics [9] and would also
have a major effect on the HIV-associated tuberculosis epidemic
[10].
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testing coverage remains low in sub-Saharan Africa. Testing
coverage documented in population-based surveys in sub-Saharan
Africa 2007–2008 ranged from 3.2% in women and 4.9% in men
in Liberia to 56.7% in women and 43.0% in men in South Africa
[11]. Barriers to HTC vary by setting and stage of the epidemic,
but have included low perceived risk [12], stigma and fear of
discrimination [13], concerns of confidentiality [14], lack of access
to free testing [12], cost of transportation [15], negative perception
of testing services [13], shortage of counselors [14] and delays in
returning testing results [14].
Kenya has scaled up HTC capacity significantly since 2003,
including traditional voluntary counseling and testing sites, mobile,
provider-initiated [16] and, more recently, door-to-door HTC
[17]. The Kenya AIDS Indicator Survey (KAIS) 2007 was the first
nationally representative survey in Kenya that measured labora-
tory testing results for HIV, herpes simplex virus type 2 (HSV-2),
syphilis, and CD4 counts for HIV-infected respondents, and
interview data on demographics, sexual behaviors, and service
utilization including prior testing history and current HIV status.
To improve HTC program planning and delivery, we analyzed
KAIS data to compare laboratory testing with self-reported HIV
results to determine the prevalence of correct knowledge of HIV
status in the country, to identify characteristics of persons aged 15–
64 years who had never tested for HIV, and to identify missed
opportunities for HIV testing.
Methods
Study design
KAIS was a nationally representative, cross-sectional, household
sero-survey of persons aged 15 to 64 years conducted from August
to December 2007. The survey used a two-stage, stratified
sampling design to provide national estimates and separate
estimates for urban and rural areas and for each of the eight
provinces. The design was comparable with the design of the 2003
Kenya Demographic and Health Survey (DHS), which also
included basic questions on HTC. The first stage involved
selecting clusters from the same sampling frame that was used
for the 2003 DHS, based on the 1999 national census, and the
second stage involved the selection of households per cluster with
equal probability of selection in the rural-urban strata within each
district. Fieldwork was conducted by 29 field teams, each
consisting of six data collectors (four interviewers and two
laboratory technicians), one supervisor and one driver. Interview-
ers and laboratory technicians were provided by the Kenya
National Bureau of Statistics and the National AIDS/STI Control
Programme, respectively. In addition to questionnaires in
Kiswahili and English, teams administered questionnaires in local
languages where necessary to accommodate respondents that were
not conversant in vernacular languages. All questionnaires were
back translated into English. Survey personnel participated in
intensive two-week training in KAIS procedures, including finger
stick, specimen collection for HIV testing and HIV education and
counseling. All participants had the option to receive their results
individually or as a couple at a nearby referral site [18].
Demographic and HIV/AIDS-specific indicators included use of
HIV testing services, HIV status, pregnancy status in women, male
circumcision, perception of HIV risk, history of sexually transmit-
ted infections, sexual risk behaviors, and use of in- and outpatient
services. Participants were asked ‘Have you ever been tested to see
if you have the virus that causes AIDS?’ and if they responded ‘yes’
then the interviewer continued asking ‘When was the last time you
were tested?’, ‘Did you get the result of that test?’, and if the
participant confirmed that he/she had received the result he/she
was asked ‘Would you be willing to share with me the result of
your (last) HIV test?’ and ‘Did the test show that you had the HIV
virus?’ Further details of KAIS methods are available elsewhere
[18].
Laboratory methods
Blood specimens obtained in households were tested at Kenya’s
national reference laboratory in Nairobi for HIV, HSV-2, syphilis
and CD4 count for HIV-infected persons. HIV testing was
performed in a serial testing algorithm by using Vironostika HIV
Uni-Form II antigen/antibody (BioMe ´rieux Bv, Boseind, Nether-
lands) and Murex HIV antigen/antibody (Abbott/Murex-Biotech
Ltd, Kent, UK) tests for HIV screening and confirmation,
respectively. HIV discrepant specimens were retested with the
two assays and polymerase chain reaction (PCR) (Roche HIV
DNA v 1.5) tests were conducted on all samples with two sets of
discrepant results. For quality control, all positive specimens and a
random sample of 5% of negative specimens were retested in a
different laboratory using the same testing algorithm. The Kalon
HSV Type 2- specific IgG EIA was used for HSV-2 testing. This
was a recombinant type-2 antigen (gG2) modified to eliminate
reactivity arising from HSV type 1 infection and at the same time
retaining the natural antigenic characteristics of HSV-2. For
syphilis testing, the Treponema pallidum particle agglutination
(TPPA) assay was used as a screening test and rapid plasma
reagin (RPR) for confirmation.
Measures
Correct knowledge of HIV status was defined as reported HIV
status validated by laboratory testing during the survey. Ever
testing was defined as self-report of one or more HIV tests prior to
the survey. We developed gender-specific models to assess factors
associated with ever having been tested for HIV in ever sexually
active persons. Predictor variables included socio-demographic
characteristics, pregnancy history and status, HSV-2 infection,
syphilis infection, perception of HIV risk, lifetime sexual partners,
condom use at last sex, number of outpatient visits in the last 12
months, number of hospitalizations in the last 12 months
(excluding outpatient or antenatal care visits), and male circum-
cision status. We reported predictors for men and women
separately because of differences in testing rates. Wealth was
defined using a DHS standard composite index of the living
standard of a household, calculated using data on a household’s
ownership of selected assets, materials used for housing construc-
tion, water access and sanitation facilities [19]. The wealth index
placed households on a continuous scale of relative wealth using
principal components analysis. Individuals were categorized
according to the score of their household and the sample was
divided into quintiles, each with an equal number of individuals,
ranging from the poorest to wealthiest.
Statistical analysis
We performed all analyses in SAS version 9.2 (SAS Institute
Inc., Cary, North Carolina, USA) using the sample survey
procedures to take into account the sampling structure (stratifica-
tion, sample weighting, and clustering), and with appropriate
domain analysis for each subpopulation of interest. Statistical
significance in cross-tabulations was assessed based on Rao-Scott
chi-square p-values. The p-value for the difference between CD4
cell counts was calculated using linear regression (PROC
SURVEYREG) on log-transformed CD4 counts. Using multivar-
iable logistic regression (PROC SURVEYLOGISTIC), we calcu-
lated adjusted odds ratios (AOR) and 95% confidence intervals
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outcome. Analyses accounted for the stratified cluster design of
the survey. Each response was weighted to account for its sampling
probability and to adjust for non-response rates. Variables with a p-
value ,0.1 in bivariate analyses were selected for final multivar-
iable models and backwards elimination was used if they did not
remain significant at a 0.05 p-value level. The category with the
strongest association was defined as the maximum negative or
positive difference from the reference 1. Two-way interactions
between variables were considered. Population estimates were
calculated based on the 2007 projected Kenyan population [20].
The gap between Kenya’s national testing target and testing
coverage documented in KAIS was calculated by subtracting 2007
testing rates from Kenya’s national target of 80% of the sexually
active population to know their HIV status [21] and multiplying
with the projected base population. Uncertainty bounds were
calculated by multiplying lower and upper confidence limits,
respectively, from KAIS estimates for sexual activity and HIV
testing.
Ethics statement
Oral informed consent was obtained from all eligible persons in
a three-stage-process: 1) to be interviewed, 2) to have a blood
specimen drawn, and 3) to have their blood stored without
identifiers for possible future tests. For each of the components, the
interviewer signed the consent form to indicate whether or not
consent was given. For participants aged 15–17 years, parental or
guardian permission was obtained. Eligible persons aged 15–17
years were then asked for their assent. Mature minors,
operationalized in KAIS as persons who were married, pregnant
or parents, or who were guardians of children aged 0–4 years
whose mother died or was HIV infected, did not need parental
consent [22]. Investigators obtained a waiver of documentation of
informed consent for all participants because the research
presented no more than minimal risk of harm to the subjects,
the waiver did not adversely affect the rights and welfare of the
participants, and the survey involved no procedures for which
written consent is normally required outside the research context
in Kenya. Survey protocols, including consent procedures, were
approved by the Ethics Review Committee of the Kenya Medical
Research Institute (KEMRI) and the Institutional Review Board of
the U.S. Centers for Disease Control and Prevention (CDC).
Results
A total of 15,853 of 19,840 eligible persons aged 15–64 years
participated in interviews and blood specimen collection, repre-
senting a response rate of 80% (women 83%, men 77%). Among
those, 1104 or 7.1% (95% CI 6.5–7.7) were HIV infected (men
5.4%, 95% CI 4.7–6.0; women: 8.4%, 95% CI 7.5–9.2). HIV
prevalence ranged between 0.8% (95% CI 0–1.6) in North-
Eastern to 8.8% (95% CI 6.3–11.4) in Nairobi and 14.9% (95%
CI 13.1–16.6) in Nyanza province. Among participants in
interviews and blood draws, 87.8% (95% CI 87.1–88.5) reported
that they had ever been sexually active (men 85.9%, 95% CI 84.7–
87.2; women 89.2%, 95% CI 88.4–90.0). Among those ever
sexually active, 27.4% (95% CI 25.6–29.2) of men and 44.2%
(95% CI 42.5–46.0) of women reported that they had ever tested
for HIV. The gap between Kenya’s national testing target and
testing coverage documented in KAIS in 2007 was an estimated
4,366,000 (uncertainty bounds 4,280,000–4,452,000) men aged
15–64 years old and 3,295,000 (uncertainty bounds 3,157,000–
3,421,000) women.
Predictors of HIV testing
There were no significant differences between HIV-infected and
HIV-uninfected persons regarding HIV testing history. Highest
ever HIV testing rates in men were found for age 30–34 years,
urban residence, Nairobi province, secondary or higher education,
highest wealth index quintile and contact with health facilities.
Women who had had an HIV test had similar characteristics as
men, but had a highest testing rate at age 20–24 (Table 1). HIV
testing rates were significantly higher among women of reproduc-
tive age (15–49 years) (49.4%, 95% CI 47.5–51.2) compared to
men in the same age group (28.9%, 95% CI 27.1–30.7,
p,0.0001). Among women aged 15–49 years who reported ever
having sex, 33.5% (95% CI 31.8–35.3) had never been tested for
HIV, 48.7% (95% CI 46.8–50.6) had their last HIV test during
antenatal care, and an additional 17.7% (95% CI 16.3–19.1) had
their last HIV test elsewhere. Among women 15–49 who had ever
been tested for HIV, 66.1% (63.6–68.6) had their last HIV test as
part of routine antenatal care (ANC). Among older adults (aged
50–64 years), HIV testing was significantly lower overall and
higher in men (20.8%, 95% CI 17.7–23.9) compared to women
(13.6%, 95% CI 11.0–16.1, p,0.0001).
Among ever sexually active adults aged 15–64 years who had
never been tested for HIV, 39.6% (95% CI 37.2–41.9) of women
and 48.9% (95% CI 46.7–51.1) of men reported they had not been
tested because they perceived themselves to be at low risk for HIV
infection; 26.7% (95% CI 24.2–29.2) of women and 20.7% (95%
CI 18.8–22.5) of men provided no reason for never having been
tested. Less than 10% of ever sexually active respondents reported
lack of access to testing, fear of others knowing about the test
result, not knowing where to go to get tested or lack of access to
treatment as reasons for not getting tested.
Table 2 presents results of bivariate and multivariable analyses
for variables associated with ever HIV testing in separate models
of ever sexually active men and women aged 15–64 years. In final
multivariable models, independent factors for testing in men
included older age, with a strong association when comparing 25–
34 year olds and 15–19 year olds (adjusted odds ratio [AOR] 2.7,
95% CI: 1.6–4.5; p=0.0002), province with the strongest
association North-Eastern versus Nairobi (AOR 0.2, 95% CI:
0.1–0.7; p=0.0102), education with the strongest association
secondary or more versus no primary education (AOR 4.4, 95%
CI: 2.2–8.9; p,0.0001), highest wealth index versus the four lower
categories combined (AOR 1.8, 95% CI: 1.3–2.5; p=0.0006),
condom use at last sex (AOR 1.6, 95% CI: 1.2–2.2; p=0.0005)
and 1 or more versus 0 outpatient visits in the last 12 months
(AOR 1.9, 95% CI: 1.4–2.5; p,0.0001). Independent factors for
HIV testing in women included age with the strongest association
age 35 and older versus 15–19 years (AOR 0.2, 95% CI: 0.1–0.3;
p,0.0001), urban versus rural (AOR 1.6, 95% CI: 1.2–2.0;
p=0.0005), province with the strongest association North-Eastern
versus Nairobi (AOR 0.1, 95% CI: 0–0.3; p,0.0001, marital
status with the strongest association divorced or separated versus
never married or cohabitating (AOR 1.9, 95% CI: 1.2–2.9;
p=0.0035), education with the strongest association secondary or
more versus no primary education (AOR 3.9, 95% CI: 2.9–5.3;
p,0.0001), ever pregnant (AOR 3.0, 95% CI: 2.2–3.9;
p,0.0001), perceived HIV risk with the strongest associations
low versus no perceived risk (AOR 0.7, 95% CI: 0.6–0.9;
p=0.0035) and moderate versus no perceived risk (AOR 0.7,
95% CI: 0.6–0.9; p=0.0007), and 1 or more versus 0
hospitalizations in the last 12 months (AOR 2.4, 95% CI: 1.6–
3.7; p,0.0001) (Table 2). While adjusted odds for ever HIV
testing in men were 2–3 times as high in all age categories 20
years and older compared to men aged 15–19 years, the adjusted
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36797Table 1. Socio-demographic characteristics of persons aged 15–64 years reporting ever HIV testing, by gender, Kenya AIDS
Indicator Survey 2007.
Male Female
N
*
n Ever
tested
% Ever
tested
95% confidence
interval N
*
n Ever
tested
% Ever
tested
95% confidence
interval
Characteristics
Total 5824 1622 27.4 25.6–29.2 7841 3466 44.2 42.5–46.0
Age
15–19 507 84 16.4 12.3–20.4 576 258 45.0 40.5–49.5
20–24 867 290 32.5 29.2–35.9 1385 903 66.8 63.4–70.2
25–29 818 285 32.7 28.4–37.0 1277 768 61.5 57.9–65.1
30–34 753 265 35.6 31.1–40.1 1107 592 52.4 48.2–56.7
35–39 666 207 30.4 25.7–35.1 923 401 41.8 37.9–45.6
40–44 567 148 26.3 22.1–30.5 718 235 30.9 26.2–35.5
45–49 539 127 21.2 17.3–25.0 708 158 20.9 17.3–24.5
50–54 415 98 24.2 19.6–28.9 500 81 16.7 12.9–20.5
55–59 373 70 19.1 13.8–24.4 414 56 15.0 9.8–20.3
60–64 319 48 18.6 11.8–25.3 233 14 5.4 2.3–8.5
Residence
Urban 1535 652 42.1 38.7–45.6 1983 1209 60.5 56.3–64.8
Rural 4289 970 23.0 21.1–25.0 5858 2257 39.0 37.0–41.0
Region
Nairobi 724 362 47.1 42.9–51.3 901 606 68.5 64.1–73.0
Central 860 229 26.7 23.4–30.0 1120 516 46.5 42.9–50.0
Coast 695 198 31.1 25.6–36.7 935 461 50.1 45.1–55.0
Eastern 917 183 19.4 16.6–22.3 1291 456 36.0 33.2–38.7
North Eastern 185 14 6.1 0.4–11.7 235 26 9.3 2.2–16.3
Nyanza 857 255 31.8 27.6–35.9 1231 513 43.6 39.1–47.7
Rift 863 210 24.8 19.2–30.3 1123 453 39.0 34.1–44.0
Western 723 171 23.7 19.8–27.7 1005 435 43.6 39.1–48.0
Marital Status
Currently married/cohabitating 3899 1088 28.1 25.8–30.3 5492 2498 45.6 43.4–47.7
Never married/cohabitating 1557 433 26.0 23.5–28.6 1085 493 44.1 40.7–47.5
Divorced/separated 281 73 25.9 20.2–31.5 594 282 50.4 45.2–55.6
Widowed 87 28 28.3 17.0–39.6 670 193 28.7 24.6–32.9
Education
No education 471 30 7.2 3.7–10.6 1347 262 20.1 16.9–23.3
Incomplete primary 1473 269 18.1 15.3–20.9 2237 904 39.1 36.3–41.9
Complete Primary 1525 391 26.1 23.5–28.8 2033 1019 50.3 47.6–53.0
Secondary or more 2355 932 37.7 35.4–40.0 2224 1281 56.4 53.6–59.1
Wealth Index
Lowest-fourth 4231 914 21.9 20.2–23.5 5869 2269 38.8 36.8–40.8
Highest 1593 708 43.2 39.7–46.7 1972 1197 59.7 57.0–62.4
Ever pregnant
No 832 325 38.9 34.9–42.9
Yes 7009 3141 44.8 42.9–46.7
Currently pregnant
No 6079 2973 48.4 46.5–50.3
Yes 508 298 60.6 55.6–65.6
Male circumcision
No 776 236 30.0 25.7–34.3
Yes 5033 1384 27.0 25.2–28.9
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to the reference group. There was a trend of increasing AOR for
ever HIV testing with higher levels of education in men and
women.
Awareness of HIV status and testing history among HIV-
infected persons
Among all laboratory-confirmed HIV-infected persons in KAIS
2007, 56.0% (95% CI 51.9–60.0) had never been tested, 27.6%
(95% CI 24.3–31.0) of HIV-infected persons reported not to be
infected based on their last HIV test, and 16.4% (95% CI 13.2–
19.6) reported being infected based on the results of their last HIV
test. HIV-infected women (31.4%, 95% CI 27.5–35.4) were
significantly more likely than men (19.5%, 95% CI 14.6–24.4,
p,0.0001) to self-report negative based on their last test result. In
total, 83.6% (95% CI 76.2–91.0) of HIV-infected adults aged 15–
64 years were unaware of their HIV infection (Figure 1). Based on
these findings, in 2007, an estimated 428,000 (95% CI 371,000–
486,000) HIV-infected men and 697,000 (95% CI 626,000–
768,000) HIV-infected women nationwide were unaware of their
HIV status.
Among laboratory-confirmed HIV-infected persons who re-
ported that they had received a negative HIV test before KAIS
2007, 56.8% (95% CI 50.3–63.3) reported that their last HIV test
was performed over 12 months prior to the survey, suggesting that
these persons may have been exposed and infected since their last
negative test. In addition, the median CD4 cell count was
significantly higher in this group (595.0 cells/mL) suggesting
possible recent infection, as compared to HIV-infected respon-
dents who also reported that they were positive (412.0 cells/mL,
p,0.0001).
Missed opportunities for HIV testing
HIV-infected, undiagnosed women who had never been tested
for HIV had the highest proportion of missed testing opportunities
during an ANC visit in the 12 months before the survey (39.1%,
95% CI 34.5–43.6) (Figure 2). In 2007, 23.2% (95% CI 17.2–29.2)
of men and 45.5% (95% CI 39.7–51.4) of women had at least one
missed opportunity for testing during an inpatient, outpatient or
ANC visit. Overall, 87.8% (95% CI 83.8–92.0) of men and 89.4%
(95% CI 86.2–92.5) of women said that they were willing to be
tested at home.
Table 1. Cont.
Male Female
N
*
n Ever
tested
% Ever
tested
95% confidence
interval N
*
n Ever
tested
% Ever
tested
95% confidence
interval
Syphilis infection
No 5656 1571 27.4 25.6–29.2 7615 3361 44.3 42.5–46.0
Yes 117 35 28.5 19.2–37.8 137 55 37.9 27.1–48.6
HSV-2 infection
No 4118 1090 26.2 24.3–28.2 4230 1914 46.3 44.3–48.4
Yes 1663 520 30.4 27.7–33.2 3531 1508 41.6 39.3–44.0
Perceived HIV risk
None 1464 393 28.4 25.0–31.7 1457 717 52.0 48.4–55.7
Low 2508 750 28.6 26.0–31.1 2541 1204 46.6 43.5–49.7
Moderate 576 159 28.8 23.7–33.9 1040 486 45.4 41.5–49.3
Great 228 74 31.1 24.2–38.0 573 280 49.1 43.7–54.4
Lifetime sexual partners
1 776 174 23.9 19.8–28.0 3141 1303 42.7 40.2–45.1
2–3 2869 813 28.1 25.9–30.3 4310 2011 46.1 44.1–48.1
4 or more 1806 528 28.0 25.1–31.0 262 104 35.3 28.4–42.2
Condom use at last sex
No 3018 424 14.9 12.9–16.9 4533 1670 37.0 35.0–39.1
Yes 645 161 25.1 21.1–29.2 359 146 45.3 38.7–51.9
Number of outpatient visits in
the last 12 months
0 5029 1345 26.4 24.6–28.1 6454 2878 45.0 43.1–46.8
1 or more 775 271 33.7 29.4–37.9 1360 581 41.2 37.5–45.0
Number of hospitalizations in
the last 12 months
0 5761 1591 27.2 25.5–29.0 7653 3348 43.7 42.0–45.5
1 or more 63 31 44.6 31.0–58.2 188 118 63.7 55.5–71.9
*Sample size varies slightly across variables due to missing data.
doi:10.1371/journal.pone.0036797.t001
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AIDS Indicator Survey 2007.
Male Female
Variables OR (95% CI)** p
AOR***
(95% CI) p OR (95% CI) p AOR (95% CI) p
Age
15–19 Reference Reference Reference Reference
20–24 2.5 (1.8–3.4) ,.0001 2.2 (1.3–3.6) 0.0023 2.5 (1.9–3.1) ,.0001 1.4 (1.0–1.9) 0.0423
25–34 2.6 (1.9–3.6) ,.0001 2.7 (1.6–4.5) 0.0002 1.6 (1.3–2.0) ,.0001 0.8 (0.6–1.0) 0.0728
35 or more 1.6 (1.2–2.2) ,.0001 2.0 (1.2–3.3) 0.0099 0.4 (0.4–0.5) ,.0001 0.2 (0.1–0.3) ,.0001
Residence
Rural Reference Reference Reference
Urban 2.4 (2.0–2.9) ,.0001 2.4 (2.0–2.9) ,.0001 1.6 (1.2–2.0) 0.0005
Province
Nairobi Reference Reference Reference Reference
Central 0.4 (0.3–0.5) ,.0001 0.7 (0.4–1.0) 0.0767 0.4 (0.3–0.5) ,.0001 0.7 (0.5–1.0) 0.0587
Coast 0.5 (0.4–0.7) ,.0001 1.5 (1.0–2.5) 0.0637 0.5 (0.3–0.6) ,.0001 1.0 (0.7–1.6) 0.8447
Eastern 0.3 (0.2–0.3) ,.0001 0.8 (0.5–1.3) 0.3184 0.3 (0.2–0.3) ,.0001 0.5 (0.3–0.8) 0.0012
North Eastern 0.1 (0–0.2) ,.0001 0.2 (0.1–0.7) 0.0102 0 (0–0.1) ,.0001 0.1 (0–0.3) ,.0001
Nyanza 0.5 (0.4–0.7) ,.0001 1.5 (0.9–2.4) 0.1152 0.4 (0.3–0.5) ,.0001 0.6 (0.4–0.8) 0.0048
Rift Valley 0.4 (0.3–0.5) ,.0001 1.1 (0.6–2.0) 0.8310 0.3 (0.2–0.4) ,.0001 0.5 (0.3–0.8) 0.0013
Western 0.4 (0.3–0.5) ,.0001 1.2 (0.7–2.0) 0.5309 0.4 (0.3–0.5) ,.0001 0.6 (0.4–0.9) 0.0268
Marital Status
Never married/cohabitating Reference Reference
Currently married/cohabitating 1.1 (0.9–1.2) 0.4800 1.8 (1.3, 2.3) ,.0001
Divorced/Separated 1.3 (1.0–1.6) 0.0194 1.9 (1.2–2.9) 0.0035
Widowed 0.5 (0.4–0.6) ,.0001 2.6 (1.4–4.9) 0.0028
Education
No primary Reference Reference Reference
Incomplete Primary 2.9 (1.7–4.7) ,.0001 2.5 (1.2–5.1) 0.0117 2.5 (2.0–3.2) ,.0001 2.1 (1.5–2.8) ,.0001
Complete Primary 4.6 (2.7–7.8) ,.0001 3.5 (1.7–7.1) 0.0007 4.0 (3.3–4.9) ,.0001 2.9 (2.1–3.8) ,.0001
Secondary or more 7.8 (4.6–13.2) ,.0001 4.4 (2.2–8.9) ,.0001 5.1 (4.1–6.4) ,.0001 3.9 (2.9–5.3) ,.0001
Wealth Index
Lowest fourth Reference Reference
Highest 2.7 (2.3–3.2) ,.0001 1.8 (1.3–2.5) 0.0006 2.3 (2.0–2.7) ,.0001
Ever pregnant
No Reference Reference
Yes 1.3 (1.1–1.5) 0.0101 3.0 (2.2–3.9) ,.0001
Currently pregnant
No Reference
Yes 1.6 (1.3–2.0) ,.0001
HSV-2 infection
No Reference Reference
Yes 1.2 (1.1–1.4) 0.0054 0.8 (0.7–0.9) 0.0005
Perceived HIV risk
None Reference Reference
Low 0.8 (0.7–1.0) 0.0317 0.7 (0.6–0.9) 0.0035
Moderate 0.8 (0.6–1.0) 0.0151 0.7 (0.6–0.9) 0.0007
Great 0.9 (0.7–1.1) 0.3454 0.9 (0.7–1.1) 0.2802
Lifetime sexual partners
1 Reference Reference
2–3 1.2 (1.0–1.6) 0.0683 1.2 (1.0–1.3) 0.0121
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KAIS showed that only one-quarter of ever sexually active men
and less than half of ever sexually active women aged 15–64 years
in Kenya in 2007 had been tested for HIV. Furthermore, more
than 80% of HIV-infected adults aged 15–64 years were unaware
of their HIV infection, and among those, one-third reported being
uninfected but had a laboratory-confirmed positive HIV test.
Time since last HIV test and higher CD4 counts suggests that
many of these had sero-converted since their last HIV test.
Considering that in 2003, only 15% of all Kenyans aged 15–49
years had ever been tested (compared to 37% of that age group in
KAIS), Kenya made substantial progress in expanding testing
[16,23]. However, overall testing coverage in 2007 remained far
below Kenya’s national goal of testing 80% of all adolescents and
adults [21], and gender difference in testing rates demonstrated a
need for special efforts to bring HIV testing to men. Higher testing
rates in women of reproductive age and the finding that half of
these women reported that they their last HIV test was during
antenatal care confirmed the importance of ANC services for HIV
testing in women but also raised the question of sufficient access to
HIV testing for women who do not get pregnant and older women
who are less likely to get HIV tested during ANC. In addition, the
large proportion of people with HIV infection reporting a
previously negative HIV test indicates ongoing incident infection
and the need for more frequent HIV testing than once in a
lifetime.
Testing rates for both men and women were higher in urban
areas (highest in the capital Nairobi), in better-educated and
Table 2. Cont.
Male Female
Variables OR (95% CI)** p
AOR***
(95% CI) p OR (95% CI) p AOR (95% CI) p
4 or more 1.2 (1.0–1.6) 0.0836 0.7 (0.5–1.0) 0.0498
Condom use at last sex
No Reference Reference Reference
Yes 1.9 (1.5–2.4) ,.0001 1.6 (1.2–2.2) 0.0005 1.4 (1.1–1.9) 0.0202
Number of outpatient visits
in the last 12 months
0 Reference Reference Reference
1 or more 1.4 (1.2–1.7) 0.0003 1.9 (1.4–2.5) ,.0001 0.9 (0.7–1.0) 0.0622
Number of hospitalizations
in the last 12 months
0 Reference Reference Reference
1 or more 2.2 (1.2–3.7) 0.0059 2.3 (1.6–3.2) ,.0001 2.4 (1.6–3.7) ,.0001
*Table includes all variables of which at least one category was significantly associated with ever testing for HIV in the bivariate analysis (p,0.01).
**OR=odds ratio, CI=confidence interval.
***AOR=adjusted odds ratio.
doi:10.1371/journal.pone.0036797.t002
Figure 1. Awareness of HIV status and testing history among HIV-infected persons, Kenya AIDS Indicator Survey 2007.
doi:10.1371/journal.pone.0036797.g001
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facilities. In multivariable analyses, variables that were indepen-
dently associated with ever HIV testing for both men and women
included age, province, education and contact to health services
(outpatient visits in men, hospitalizations in women). In men only,
wealth index and condom use at last sex were independently
associated with ever HIV testing. In women only, marital status,
ever having been pregnant, and perceived HIV risk were
independently associated with ever HIV testing. The considerably
lower odds for ever testing in women aged 35 years and older
compared to men of that age confirmed that women are testing at
younger age, most likely driven by ANC services during
pregnancy. All provinces with significant AOR were negatively
associated with ever HIV testing when compared to Nairobi. This
included North-Eastern, the province with limited need for HIV
testing, given a HIV prevalence of ,1%, and Nyanza with a 40%
lower odds for ever HIV testing in women yet an HIV prevalence
in women of 17% compared to 10% in Nairobi. Nyanza is a
mostly rural province on the shore of Lake Victoria with the
highest rates for HIV in the country, at least partially due to a low
prevalence of male circumcision, while North Eastern province is
less populated and ethnic groups in this area traditionally
circumcise. Independent associations with ever HIV testing of
both education and wealth (men only) in our study highlight
linkages between HIV infection, access to services, and socio-
economic status [24]. The main reason for not testing for HIV
among those never previously tested was low perception of risk,
which has been also reported from Uganda [12].
We found that considerable opportunities for testing were
missed during general or pregnancy-specific contacts with health
facilities. Our study suggests that more than 90% of all persons in
Kenya with undiagnosed HIV infection who had never been
tested could potentially be identified through a combination of
provider-initiated testing and door-to-door testing in high preva-
lence provinces. However, coverage of door-to-door testing can
decrease when family members cannot be reached at home [25].
The 2008 National Guidelines for HIV Testing and Counselling
in Kenya promote a diversified approach to reduce the number of
missed opportunities for providing HTC including client-initiated,
provider-initiated, self-testing, home-based testing and mass HIV
testing campaigns [21]. The guidelines call for integration of HTC
into other health services to allow for early detection and better
health care for persons living with HIV [21]. Our findings show
that targeting sexually active men in general, sexually active non-
pregnant and older women (e.g. $35 years), and rural and
disadvantaged populations should be a priority for prevention
efforts, as well as increasing general knowledge about HIV risks in
a country with a prevalence of 7%. Standardized quality-control
measures for HIV testing, partner testing and mutual disclosure of
testing results are additional programmatic implications.
In times of increasing restrictions of funding, national strategies
need to consider the most cost-efficient interventions. Menzies and
colleagues estimated costs and effectiveness of four HTC strategies
in Uganda in 2003–2005 [26]. Door-to-door HCT had the lowest
cost per client tested ($8.29) and per client who tested for the first
time ($9.21) compared to costs of $11.68 and $14.73, respectively,
during hospital-based HCT. However, cost per HIV-positive
individual identified was considerably higher for door-to-door
HCT ($163.93) than for hospital-based HCT ($43.10). Door-to-
door HCT was able to reach more clients as couples (21.6%) than
hospital-based HCT (3.2%). Although these results may not be
entirely transferable to Kenya, this study confirmed that a mixture
of different types of HTC facilities will allow contributing to
Kenya’s national targets of achieving 80% of the sexually active
Figure 2. Percentages and 95% confidence intervals of missed opportunities for HIV testing among ever sexually active, HIV-
infected undiagnosed persons aged 15–64 years who reported never having been tested for HIV, by gender, Kenya AIDS Indicator
Survey 2007.
doi:10.1371/journal.pone.0036797.g002
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effects that have been shown to be strongest among HIV-positive
clients and discordant couples [4], and identify as many persons as
possible living with HIV but do not know their status. Further
operational research is needed to determine the ideal mixture of
services for a country like Kenya and the frequency of repeat
testing needed for specific risk populations and in high HIV
prevalence areas to identify persons with recent infection early and
enroll them into care and treatment programmes. Home-based
testing was acceptable to over 80% of persons aged 15–64 years in
KAIS 2007 and may help achieve the national testing goal.
Program and survey data in Kenya suggest that testing coverage
has continued to increase since KAIS. In 2008–9 [27], 40% of
men and 57% of women aged 15–49 years in Kenya had been
tested for HIV and had received results at least once in their
lifetime (up from 26% and 45% for age 15–49 years, respectively,
in KAIS 2007). Nevertheless, given persistent incidence [28], on-
going provision of testing will be critical for Kenya’s HIV
prevention, care and treatment efforts. While testing rates
continue to increase in the country and this may place Kenya
more towards the higher end of testing rates in sub-Saharan Africa
[11], consolidated efforts are needed to reach Kenya’s national
goal and allow all HIV-infected persons access to life saving
treatment. Similar proportions of persons unaware of their HIV
status as in our study may be found in other countries in Sub-
Saharan Africa with a generalized HIV epidemic similar to
Kenya’s, indicating the need to include both laboratory testing
results for HIV and interview data on prior testing history and
current HIV status in population-based HIV surveys.
Our study had several limitations. Cross-sectional surveys do
not allow for determination of the sequence of events in time.
KAIS was not designed to assess HIV testing among high-risk
populations, such as sex workers, men who have sex with men, or
intravenous drug users (Kenya has increased surveillance efforts
for these populations since 2010). Some data were not available
from the study, e.g., whether respondents had not tested for HIV
because no transport was available to reach a testing site or they
were not able to pay for the transport, or whether they had tested
as a couple. There is no generally accepted definition of a high
HIV prevalence area; therefore, missed opportunities were
reported across Kenya without excluding provinces with relatively
low prevalence such as North-Eastern. High rates of undiagnosed
infection suggest limited coverage of testing services and relatively
high incidence; however, they may also partially reflect reporting
bias due to misunderstanding of prior results, denial, misreporting,
or false-negative test results. Finally, Kenya’s population structure
with over 40 ethnic groups of considerable cultural differences
may have resulted in some differences in self-reporting. The
example of reporting bias of HIV results was discussed above. In
general, the direction and magnitude of any potential reporting
bias is unknown.
In spite of these limitations, by including for the first time
questions on HIV status and CD4 count testing among HIV-
infected persons, Kenya’s nationally representative HIV survey
helped inform HIV program planning with unprecedented detail.
Our findings illuminated both the high rates of undiagnosed
infection throughout Kenya and the clear opportunities for
expanding testing coverage to meet the national and 2008 United
Nations goals of universal access to HIV prevention, treatment,
care and support [29]. Knowledge of HIV status could help
protect millions of people from transmitting HIV unknowingly,
from suffering unnecessarily from opportunistic infections, and
from dying prematurely with no access to treatment. Three
decades into an epidemic, which has already claimed more than
an estimated 15 million lives in Africa alone [30], the urgency of
universal testing access could not be clearer.
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